Abound Bio
Pittsburgh
About Abound Bio
Abound Bio specializes in generating antibody-based biological therapeutics to meet medical needs in the fields of cancer and infectious disease. Its team has developed several very large (>1011 clones each), diverse human antibody libraries in standard Fab and scFv, and unique VH domain formats. It can rapidly (days to weeks) discover novel, high affinity, binders in multiple formats, engineer them if needed to improve their drugability (developability), and convert them for multiple uses including IgGs, multispecific, CARs, fusion proteins, and antibody-drug conjugates (ADCs).
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Website: aboundbio.com
- Phone: 412-209.4544
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/abound-bio-2710432 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.